Doi:10.1046/j.1523-1747.1999.00708.x Ionescu M, Frohman LA
Licensed US compounding pharmacy only
Ergocryptine and other ergot alkaloids stimulate the release of [3H] dopamine from rat striatal synaptosomes
For a brain that has a complicated relationship with fullness, these sensations can feel like a sign to avoid food altogether, unintentionally reinforcing a fear of eating
Since the carrier molecule of fatty acids, acyl-CoA, can not cross the cell membrane of the mitochondria, a deficiency of carnitine causes a reduction in the concentration of fatty acids in the mitochondria and, consequently, a reduced production of energy
The bottom line While there are no magic solutions to address the effects of GLP-1 medications, there are strategies to reduce bothersome effects